Evidence map›Paper›PMID 39900942›Full record

ArticleScientific reports2025

Author Correction: Normal tissue radioprotection by amifostine via Warburg-type effects.

Michael I Koukourakis, Alexandra Giatromanolaki, Christos E Zois, Dimitra Kalamida, Stamatia Pouliliou, Ilias V Karagounis, Tzu-Lan Yeh, Martine I Abboud, Timothy D W Claridge, Christopher J Schofield and 4 more

Abstract readPublished Erratum
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Michael I KoukourakisDepartment of Radiotherapy/Oncology, Democritus University of Thrace, 68100, Alexandroupolis, Greece. targ@her.forthnet.gr.
Alexandra GiatromanolakiDepartment of Pathology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Christos E ZoisDepartment of Radiotherapy/Oncology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Dimitra KalamidaDepartment of Radiotherapy/Oncology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Stamatia PouliliouDepartment of Radiotherapy/Oncology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Ilias V KaragounisDepartment of Radiotherapy/Oncology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Tzu-Lan YehThe Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, UK.
Martine I AbboudThe Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, UK.
Timothy D W ClaridgeThe Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, UK.
Christopher J SchofieldThe Chemistry Research Laboratory, Mansfield Road, Oxford, OX1 3TA, UK.
Efthimios SivridisDepartment of Pathology, Democritus University of Thrace, 68100, Alexandroupolis, Greece.
Costantinos SimopoulosLaboratory of Experimental Surgery, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece.
Savvas P TokmakidisDepartment of Physical Education and Sports Science, Democritus University of Thrace, Komotini, Greece.
Adrian L HarrisCancer Research UK, Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39900942
PMCPMC11790863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.